Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Enhancing social and linguistic skills in children with autism: A semi-randomized controlled clinical trial of a virtual reality-based communicative rehabilitation programme.

Created on 29 Aug 2026

Authors

Hassnaa O Mohammed, Ehab M Eid, Enas Rady Younes

Published in

Journal of neuropsychology. Aug 29, 2026. Epub Aug 29, 2026.

Abstract

Autism spectrum disorder (ASD) is characterized by persistent deficits in social communication, and conventional therapies often struggle to facilitate the generalization of these skills to real-world settings. This study aimed to determine the effectiveness of a virtual reality (VR)-based communication rehabilitation intervention as a supplement to conventional treatment for improving the linguistic and social communication skills of Arabic-speaking Egyptian children with ASD. A clinical trial with a pretest-posttest control group design was employed, wherein 60 children aged 4-6 years with mild to moderate ASD were assigned to either VR plus conventional therapy (Group I, n = 30) or conventional therapy alone (Group II, n = 30). Over 6 months, participants received 2 weekly 30-min sessions. Outcomes were measured at baseline, immediately post-intervention and at a 3-month follow-up using the Preschool Language Scale-Fourth Edition, the Childhood Autism Rating Scale-Second Edition and an ASD Social Skills Scale. Group I demonstrated statistically significant improvements in receptive and expressive language ages (p < .001) and total social skills scores (p < .001) compared to Group II. Crucially, these therapeutic gains were sustained at the 3-month follow-up with no significant deterioration (p > .05). VR-based communication rehabilitation is a highly effective and sustainable intervention for supplementing language and social skills in young children with ASD. Its integration into clinical practice provides a scalable, engaging and culturally adaptable platform for neurodevelopmental care.

PMID:
42667252
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement